10. 現今規模
TAPI(Teva Active Pharmaceutical Ingredients)
獨立於Teva以外的研發、原料藥廠
1940年代成立
1991年起大幅併購其他原料廠
2012年營收達7.96億美元
總部位於以色列
員工5,000名左右
分布於全球超過20個據點
R&D部分包括750個科學家
共有7個研究中心
December 2008 – Teva Acquisition of Barr-Pliva in Croatia
July 2008 – Teva Acquisition of Bentley in Spain
April 2008 – TAPI Acquisition of Archimica in Puerto Rico
2006 – Acquisition of Wanma in China
2005 – Acquisition of IVAX API in Czech Republic and Puerto Rico
2004 – Acquisition of Sicor API in Italy, Mexico and Switzerland
2003 – Acquisition of RDL in India
2002 – Acquisition of PFC in Italy
1996 – Acquisition of BIOCRAFT in Missouri (US)
1995 – Foundation of TEVA-TECH in Israel
1995 – Acquisition of ICI in Italy & BIOGAL in Hungary
1991 – Acquisition of PROSINTEX in Italy